
Curaleaf Holdings has received competition law approvals in Germany and Canada for its proposed acquisition of Aurora Cannabis. These clearances remove major regulatory hurdles, allowing Curaleaf to proceed with its offer to purchase all outstanding shares of Aurora, which expires December 4, 2026. The approvals provide greater certainty and a faster path to closing, strengthening Curaleaf's bid against competing offers. Aurora shareholders are encouraged to consider this advantage when evaluating proposals.
As of Nov 10, 2026 20:02 WIB, Aurora Cannabis Inc (ACB) is trading at USD 5.20 on Pluang, showing a 0.78% increase in the last day. The company has a market capitalization of $339.90 million and an enterprise value of $295.86 million. The typical hold time for ACB on Pluang is 25 days, highlighting active investor interest around this health sector stock.